Scinai immunotherapeutics establishes u.s. subsidiary for cdmo business unit, scinai bioservices inc.

Jerusalem , dec. 16, 2024 /prnewswire/ -- scinai immunotherapeutics ltd. (nasdaq: scni) ("scinai" or the "company"), a biopharmaceutical company focused on developing inflammation and immunology (i&i) biological products and providing cdmo services through its scinai bioservices business unit, announced today the establishment of a u.s.-based subsidiary for its contract development and manufacturing services.
CDMO Ratings Summary
CDMO Quant Ranking